ISIS PHARMACEUTICALS, INC DEF 14A 6-10-2014

Company

IONIS PHARMACEUTICALS INC

Filed

April 25, 2014

Period of Report

June 10, 2014

Accession Number

0001140361-14-017588

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →